98%
921
2 minutes
20
Background: Numerous grading scales were proposed for subarachnoid hemorrhage (SAH) to assess the likelihood of unfavorable neurological outcomes (UO) and the risk of delayed cerebral ischemia (DCI). We aimed to validate the Hemorrhage, Age, Treatment, Clinical Status, and Hydrocephalus (HATCH) score and the VASOGRADE, a simple grading scale for prediction of DCI after aneurysmal SAH.
Methods: This was a retrospective single-center study of patients with nontraumatic SAH (January 2016 to December 2021) admitted to the intensive care unit. We performed a receiver operating characteristic (ROC) curve analysis to assess the discriminative ability of the HATCH and the VASOGRADE to identify patients who had UO at 3 months (defined as Glasgow Outcome Scale score of 1-3), hospital mortality, and DCI and compared their performance with the World Federation of Neurosurgical Surgeons, the modified Fisher, the Sequential Organ Failure Assessment, and the Acute Physiology and Chronic Health Evaluation II scales. We performed a multivariate logistic regression analysis to assess the association between HATCH and UO at 3 months and between VASOGRADE and DCI.
Results: We included 262 consecutive patients with nontraumatic SAH. DCI was observed in 82 patients (31.3%), whereas 78 patients (29.8%) died during hospital stay and 133 patients (51%) had UO at 3 months. HATCH was independently associated with UO (odds ratio 1.61, 95% confidence interval [CI] 1.36-1.90) and had an area under the ROC curve (AUROC) of 0.83 (95% CI 0.77-0.88), comparable to the Acute Physiology and Chronic Health Evaluation II (AUROC 0.84, 95% CI 0.79-0.89) and Sequential Organ Failure Assessment (AUROC 0.83, 95% CI 0.77-0.88).
Conclusions: Hemorrhage, Age, Treatment, Clinical Status, and Hydrocephalus and VASOGARDE scores had a good performance to predict UO or in-hospital mortality and DCI, respectively; however, their performance did not outperform nonspecific routinely used scores.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12028-025-02270-9 | DOI Listing |
Ocular relapse in pediatric acute lymphoblastic leukemia (ALL) is rare and typically associated with central nervous system or bone marrow involvement. Anterior segment infiltration as the sole manifestation of relapse is exceptionally uncommon and may mimic noninfectious uveitis, leading to diagnostic delay. We report the case of a 4-year-old boy with a history of B-cell precursor ALL, diagnosed at age 2 and treated according to the ALL IC BFM 2009 protocol.
View Article and Find Full Text PDFWorld J Pediatr Congenit Heart Surg
September 2025
Heart Center, Children's Healthcare of Atlanta; Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA.
Delayed sternal closure (DSC) is frequently utilized to facilitate the recovery of myocardial function and edema following the Norwood procedure. At our institution, most patients undergo primary sternal closure (PSC), unless specified high-risk characteristics are present. We sought to analyze the outcomes of our approach.
View Article and Find Full Text PDFPLoS One
September 2025
Wake Forest University School of Medicine, Department of Implementation Science, Winston-Salem, North Carolina, United States of America.
Background: Hepatitis C virus (HCV) and injection drug use among young women are dramatically rising in the rural United States. From 2004 to 2017, heroin use among non-pregnant women increased 22.4% biennially, mirroring increases in HCV cases, especially among younger populations.
View Article and Find Full Text PDFWorld J Pediatr Congenit Heart Surg
September 2025
Congenital Heart Center, Departments of Surgery and Pediatrics, University of Florida, Gainesville, FL, USA.
This analysis evaluates the longitudinal impact of extracorporeal membrane oxygenation (ECMO) and ventricular assist device (VAD) on the progression of motor delay and cognitive delay in pediatric heart transplant recipients. The United Network for Organ Sharing Registry was queried for pediatric patients (<18 years) who received a heart transplant between 2008 and 2022 and were bridged-to-transplantation with either ECMO or VAD. Patients were further stratified based on the progression of delay status pretransplant to post-transplant.
View Article and Find Full Text PDFClin J Am Soc Nephrol
September 2025
University College London Great Ormond Street Hospital for Children and Institute of Child Health, London, UK.
Background: Experience with icodextrin use in children on long-term peritoneal dialysis is limited. We describe international icodextrin prescription practices and their impact on clinical outcomes: ultrafiltration, blood pressure control, residual kidney function (RKF), technique and patient survival.
Methods: We included patients under 21 years enrolled in the International Pediatric Peritoneal Dialysis Network (IPPN) between 2007 and 2024, on automated PD with a daytime dwell.